

Malaria
Malaria is a disease caused by Plasmodium parasites. The parasites are spread to people through the bites of infected female Anopheles mosquitoes, called malaria vectors. There are five parasite species that cause malaria in humans, and two of these species (P. falciparum and P. vivax) pose the greatest threat. Malaria is a major disease burden in tropical low-income countries, especially in Sub-Saharan Africa. People with malaria often experience a fever, chills and flu-like symptoms. Left untreated, they may develop severe complications and die.
Over 200 of our Swiss TPH staff and students are particularly passionate about malaria in a broad range of fields. We conduct basic research on the biology of Plasmodium spp., including gene regulation and parasite-host interactions. We identify and test new diagnostics, drugs, immunotherapies and vaccines for malaria in collaboration with product development partnerships and the private sector. We study the malaria vector Anopheles spp. to develop new effective vector control tools and strategies. And then, we validate these interventions in large-scale implementation studies with partners in endemic countries.
We apply innovative approaches in computational sciences, statistics, and mathematical modelling to increase our understanding of the biology and transmission of malaria and the impact of interventions. Finally, we use the generated evidence and experience to support decision-makers in malaria endemic countries and globally in developing novel interventions and implementing effective malaria control and elimination strategies. We provide this support as the designated WHO Collaborating Centre for Modelling, Monitoring and Training for Malaria Control and Elimination.

